1. The critical role of background rates of possible adverse events in the assessment of COVID-19 vaccine safety;Black;Vaccine,2021
2. Developing standard safety outcomes for COVID-19 vaccines;Buttery;Vaccine,2021
3. World Health Organization. COVID-19 vaccines: safety surveillance manual 2021 [accessed 13 November 2023]. [Available from: https://www.who.int/publications/i/item/9789240032781].
4. Law B. SO2-D2. 1.2 Priority List of COVID-19 Adverse events of special interest: Quarterly update December 2020 [accessed 9 November 2023]. [Available from: https://brightoncollaboration.us/wp-content/uploads/2023/05/SO2_D2.1.2_V1.2_COVID-19_AESI-update_V1.3.pdf].
5. European Network of Centres for Pharmacoepidemiology and Pharmacovigilance(ENCePP). Background rates of Adverse Events of Special Interest for monitoring COVID-19 vaccines 2021 [accessed 13 November 2023]. [Available from: https://www.encepp.eu/encepp/viewResource.htm?id=37274].